NDC 0006-5363 – Steglatro
Ertugliflozin Pidolate 5 mg/1 · Tablet, Film Coated · Oral
Product NDC0006-5363
Product details
- Brand name
- Steglatro
- Generic name
- Ertugliflozin
- Labeler
- Merck Sharp & Dohme LLC
- Dosage form
- Tablet, Film Coated
- Route
- Oral
- Marketing category
- NDA · NDA209803
- Marketed since
- December 19, 2017
- Listing expires
- December 31, 2027
Active ingredients
- Ertugliflozin Pidolate 5 mg/1
Package NDC codes (5)
| Package NDC | Description | Since |
|---|---|---|
| 0006-5363-03 | 30 TABLET, FILM COATED in 1 BOTTLE (0006-5363-03) | Dec 19, 2017 |
| 0006-5363-06 | 90 TABLET, FILM COATED in 1 BOTTLE (0006-5363-06) | Dec 19, 2017 |
| 0006-5363-07 | 500 TABLET, FILM COATED in 1 BOTTLE (0006-5363-07) | Dec 19, 2017 |
| 0006-5363-09 | 2 BOTTLE in 1 CARTON (0006-5363-09) / 7 TABLET, FILM COATED in 1 BOTTLE (0006-5363-08) | Dec 19, 2017 |
| 0006-5363-10 | 30 TABLET, FILM COATED in 1 BOTTLE (0006-5363-10) | Dec 19, 2017 |
Recalls mentioning this NDC
- D-0524-2021 Jun 2, 2021 · Class II
CGMP Deviations: Intermittent exposure to temperature excursion during storage.
Other Steglatro products
- 0006-5364 Ertugliflozin Pidolate 15 mg/1 · Tablet, Film Coated · Merck Sharp & Dohme LLC